Urologix sets early US launch for Targis
This article was originally published in Clinica
Executive Summary
Urologix has brought forward the US launch date for its microwave system for the treatment of benign prostatic hyperplasia (BPH) to the middle of the fourth quarter, due to the rapidity of the FDA's review. FDA approval to market Targis was received only 180 days after filing.